Cypress Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Cypress Advisory Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Buy	5,249 +156	+3%	+$36.4K	1.03%	31
2026 Q1	$1.25M	Hold	5,093	–	–	0.95%	32
2025 Q4	$1.05M	Hold	5,093	–	–	0.77%	41
2025 Q3	$944K	Hold	5,093	–	–	0.7%	46
2025 Q2	$778K	Sell	5,093 -187	-4%	-$28.7K	0.6%	47
2025 Q1	$876K	Sell	5,280 -380	-7%	-$59.5K	0.8%	33
2024 Q4	$818K	Buy	+5,660	New	+$877K	0.75%	37

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cypress Advisory Group's JNJ Position: Q2 2026 in Review

Cypress Advisory Group increased its Johnson & Johnson (JNJ) stake by 3.1% in Q2 2026, buying an estimated $36.4K and bringing the position to 5,249 shares worth $1.33M. The position accounts for 1.03% of the portfolio, ranked #31.

Cypress Advisory Group first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Cypress Advisory Group held 5,249 shares of Johnson & Johnson worth $1.33M as of Q2 2026.
Cypress Advisory Group bought 156 Johnson & Johnson shares in Q2 2026, an estimated $36.4K.
Johnson & Johnson made up 1.03% of Cypress Advisory Group's portfolio in Q2 2026, its #31 holding.
Cypress Advisory Group first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cypress Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.